HOME >> MEDICINE >> NEWS
Political commitment and strong health systems needed to control tropical worm disease

Many middle-income countries have made great progress in the control of the tropical worm disease schistosomiasis, but political commitment and strong health systems are now needed to help countries with fewer resources, state the authors of a Seminar in this week's issue of the Lancet.

Schistosomiasis is a wide-spread parasitic disease caused by infection with flatworms. The disease mainly affects people living in tropical countries that come into contact with infested waters but it can also affect travelers. Up to 200 million people are estimated to be infected worldwide. Dependent of the species of worm and stage of disease, symptoms may include diarrhoea, liver damage and portal hypertension, or bloody urine, and bladder/kidney damage.

Wide-scale drug treatment combined with socio-economic progress has greatly reduced the impact of schistosomiasis in middle-income countries such as Egypt, China, Brazil, the Philippines and Morocco. However, low-income countries, especially those in sub-Saharan Africa, have had greater difficulties in implementing and sustaining drug-based control strategies. Early pilot projects in countries such as Mali and Madagascar showed promising early results but floundered when foreign assistance ended.

Author Professor Bruno Gryseels states: "The fight against schistosomiasis is not just a matter of distributing drugs; establishment of strong health systems that are able to take care of patients and to integrate sustainable control measures is a far greater and more important challenge."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
21-Sep-2006


Page: 1

Related medicine news :

1. Political party policies to reduce social inequalities have better health outcomes
2. Political prejudice preventing progress on prison health
3. New AIDS Tech Transfers reinforce Roche commitment to strengthen African manufacturing
4. Rockefeller Foundation will not abandon its commitments to public health
5. AAMRI welcomes Canberras fresh commitment to medical research funding
6. Autism Speaks makes major funding commitment for unprecedented national autism database
7. Americans think commitment to health research should be stronger
8. Eight million dollar commitment to schizophrenia research
9. Smoking may strongly increase long-term risk of eye disease
10. Novel candidate biomarker for heart failure also strongly predicts risk of death
11. Nancy Brinker and Lance Armstrong honored with Centennial Medals at the AACR 2007 Annual Meeting

Post Your Comments:
(Date:7/28/2014)... (PRWEB) July 28, 2014 Community Health ... primary medical, dental, and pharmacy services, has released an ... chronic disease management . Founded in 1983, the ... to those of the county that face barriers to ... To make an appointment at the CHC, click here: ...
(Date:7/28/2014)... South Carolina (PRWEB) July 28, 2014 ... enjoy their first bite of food best, with each ... Over-indulging, the researchers found, can actually serve to sabotage ... overindulge in foods they enjoy, not realizing the effect," ... "This is the argument for moderation, if we needed ...
(Date:7/28/2014)... Myers, Florida (PRWEB) July 28, 2014 ... management business process outsourcing (BPO) for Fortune 500 brands, ... 2,500 jobs across its locations in Wisconsin, California, Florida ... will be based at its Fort Myers campus, and ... available. , The hiring is to support several health-insurance ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Maternal and ... Allan Tucker Award, which will be presented at the ... on October 29th at the Westmoreland Club in Wilkes-Barre. ... County Commissioner and long-time employee of MFHS. She ... leader, political activist, health advocate, and champion for women, ...
(Date:7/28/2014)... 2014 Labors.at, Austria’s largest and ... Healthcare Relationship Cloud™ to fuel its growth initiatives. ... to 8,000 patients daily and performs up to ... up to doubling its volume within the next ... cutting-edge 10,000 square meter facility pushed our team ...
Breaking Medicine News(10 mins):Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 3Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 2Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 3Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 4Health News:MFHS Seeking Nominations for Rose Allan Tucker Award 2Health News:Austrian Laboratory Leader, Labors.at, Fuels Growth with the hc1® Healthcare Relationship Cloud™ 2
(Date:7/28/2014)... 2014  ProteinSimple announced today that it has launched ... assay allows users to detect all proteins separated in ... users can analyze proteins without the need for an ... protein analysis as we know it today. First, the Simple ... no messy gels, no transfer tanks, no blots, no ...
(Date:7/28/2014)... und LONDON , July ... , Ziel der Zusammenarbeit sind Entwicklung und Kommerzialisierung ... Plasmaproben zur Steuerung von Therapien mit IRESSA bei ... Neuer Bluttest basiert auf QIAGENs von der ... Rotor-Gene Q, einer Automationsplattform der QIAsymphony-Produktfamilie, laufen  ...
(Date:7/28/2014)... and LONDON , July 28, ... aims to create and commercialize companion diagnostic using genomic ... IRESSA  for non-small cell lung cancer patients  ...   EGFR test and is planned to run on Rotor-Gene Q, member ... Project enabled by AstraZeneca master framework agreement adds to ...
Breaking Medicine Technology:ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
Cached News: